Report of Foreign Issuer (6-k)
May 03 2017 - 6:07AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
For the month of May 2017
Commission File No.:001-35773
REDHILL BIOPHARMA LTD.
(Translation of registrant’s name into English)
21 Ha'arba'a Street, Tel Aviv, 64739, Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file
annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the Registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate by check mark if the Registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
Attached hereto and incorporated by reference herein is a press release
issued by the Registrant entitled:
" RedHill Biopharma Reports 2017 First Quarter Financial Results”
Exhibit 1: Registrant's press release entitled "
RedHill Biopharma
Reports 2017 First Quarter Financial Results
”.
Exhibit 2: Registrant’s condensed consolidated interim unaudited
financial information as of March 31, 2017 and for the three months then ended.
This Form 6-K is incorporated by reference into the Company's Registration Statements
on Form S-8 filed with the Securities and Exchange Commission on May 2, 2013 (Registration No. 333-188286) and on October 29, 2015
(Registration No. 333-207654) and its Registration Statement on Form F-3 filed with the Securities and Exchange Commission on February
25, 2016 (Registration No. 333- 209702).
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
REDHILL BIOPHARMA LTD.
(the "Registrant")
|
Date: May 3, 2017
|
|
By:
|
/s/
Dror Ben-Asher
|
|
|
|
|
Dror Ben-Asher
|
|
|
|
|
Chief Executive Officer
|
|
Redhill Biopharma (NASDAQ:RDHL)
Historical Stock Chart
From Apr 2024 to May 2024
Redhill Biopharma (NASDAQ:RDHL)
Historical Stock Chart
From May 2023 to May 2024